General Information of the Compound
Compound ID |
CP0062216
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-phenyl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide
Show/Hide
|
||||||||||||||||||
Synonyms |
1-Piperazinecarboxamide, N-phenyl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)-
62521S57AU
681136-29-8
AC1MDCTI
AC1Q5LMB
ACMC-20emff
BCP06935
BHBOSTKQCZEAJM-UHFFFAOYSA-N
CHEMBL460273
CTK1J2536
DTXSID00384599
EX-A2218
GTPL5206
HMS1662H10
HMS2801K13
HMS3651L15
JNJ 1661010
JNJ-1661010
JNJ1661010
MLS001111246
MolPort-001-806-365
N-PHENYL-4-(3-PHENYL-1,2,4-THIADIAZOL-5-YL)-1-PIPERAZINECARBOXAMIDE
N-phenyl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide
Oprea1_746619
PMID26413912-Compound-13
Piperazine urea derivative 1
SCHEMBL1164398
UNII-62521S57AU
cid_2809273
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C19H19N5OS
|
||||||||||||||||||
Molecular Weight |
365.462
|
||||||||||||||||||
Canonical SMILES |
O=C(Nc1ccccc1)N1CCN(CC1)c1nc(ns1)-c1ccccc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C19H19N5OS/c25-18(20-16-9-5-2-6-10-16)23-11-13-24(14-12-23)19-21-17(22-26-19)15-7-3-1-4-8-15/h1-10H,11-14H2,(H,20,25)
Show/Hide
|
||||||||||||||||||
InChIKey |
BHBOSTKQCZEAJM-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( Piperazine urea derivative 1 )
Drug Name | Piperazine urea derivative 1 |
---|
Drug 2 ( JNJ-1661010 )
Drug Name | JNJ-1661010 |
---|